Source: Health Products Regulatory Authority (ZA) Publisher: RANBAXY (SA) (PTY) LTD, a Sun Pharma company, Ground Floor, Tugela House, Riverside Office Park, 1303 Heuwel Avenue, Centurion
TELGEN 40 (Tablets).
TELGEN 80 (Tablets).
| Pharmaceutical Form |
|---|
|
TELGEN 40: Off white to light yellow coloured, oblong tablets, debossed with ‘T12’ on one side and plain on other side. TELGEN 80: Off white to light yellow coloured, oblong tablets, debossed with ‘T13’ on one side and plain on other side. |
TELGEN 40:
Each tablet contains telmisartan 40 mg.
Contains sugar: sorbitol 174,64 mg per tablet.
Contain sodium hydroxide 3,36 mg per tablet.
TELGEN 80:
Each tablet contains telmisartan 80 mg.
Contains sugar: sorbitol 349,28 mg per tablet.
Contains sodium hydroxide 6,72 mg per tablet.
For full list of excipients, see section 6.1
| Active Ingredient |
|---|
|
Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting. |
| List of Excipients |
|---|
|
TELGEN also contains the following excipients: Magnesium stearate |
Carton contains 30 tablets packed in desiccant embedded silver cold form blisters or silver cold form blisters of 10 tablets each.
RANBAXY (SA) (PTY) LTD, a Sun Pharma company, Ground Floor, Tugela House, Riverside Office Park, 1303 Heuwel Avenue, Centurion
TELGEN 40: 45/7.1.3/0610
TELGEN 80: 45/7.1.3/0611
Date of registration: 10 October 2013
Date of last approval: 20 March 2024
| Drug | Countries | |
|---|---|---|
| TELGEN | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.